CIK 0000822370
- Non-accelerated filer
- Smaller reporting company
Emmaus Life Sciences, Inc.
Sign in to watch- Ticker
- EMMA
- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 870419387
- Phone
- +1 310-214-0065
- Business address
- 21250 HAWTHORNE BOULEVARD, SUITE 800, TORRANCE, CA, 90503
- Former names
- MYnd Analytics, Inc., CNS RESPONSE, INC., STRATIVATION, INC., SalesTactix, Inc., AGE RESEARCH INC
- 4 Grant or award Director acquired 18,000 shares (grant or award)
- 4 Grant or award Director acquired 12,000 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market buy Director bought 5,000 shares at $3.34 ($16,684)
- 4 Open-market buy Director bought 5,000 shares at $3.65 ($18,242)
- 4 Open-market buy Director bought 5,000 shares at $4.00 ($19,996)
- 4 Open-market buy Director bought 10,000 shares at an average $4.25 ($42,493)
- 4 Open-market buy Director bought 10,000 shares at an average $4.47 ($44,695)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Grant or award Director acquired 25,000 shares (grant or award)
- 4 Open-market buy Director bought 9,878 shares at $6.46 ($63,843)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Open-market buy 10% owner bought 160,000 shares at $6.25 ($1,000,000)
- 4 Grant or award Director acquired 40,000 shares (grant or award)
- 4 Grant or award Director acquired 5,000 shares (grant or award)
- 4 Grant or award Director acquired 32,000 shares (grant or award)
Page 14 of 25 · 488 filings